Merit Medical Systems (NASDAQ:MMSI) Chairman Fred Lampropoulos Sells 10,000 Shares

Merit Medical Systems, Inc. (NASDAQ:MMSI) Chairman Fred Lampropoulos sold 10,000 shares of Merit Medical Systems stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $88.04, for a total transaction of $880,400.00. Following the completion of the sale, the chairman directly owned 1,019,955 shares in the company, valued at approximately $89,796,838.20. The trade was a 0.97% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Merit Medical Systems Trading Down 0.2%

NASDAQ MMSI opened at $87.41 on Thursday. The company has a quick ratio of 2.66, a current ratio of 4.09 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $5.18 billion, a P/E ratio of 44.37, a P/E/G ratio of 2.62 and a beta of 0.64. Merit Medical Systems, Inc. has a 52-week low of $78.12 and a 52-week high of $111.45. The firm has a 50-day moving average price of $84.08 and a 200 day moving average price of $88.36.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, October 30th. The medical instruments supplier reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.10. The company had revenue of $384.16 million for the quarter, compared to analyst estimates of $371.69 million. Merit Medical Systems had a return on equity of 15.07% and a net margin of 8.31%.The firm’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.86 EPS. Merit Medical Systems has set its FY 2025 guidance at 3.660-3.790 EPS. Equities research analysts expect that Merit Medical Systems, Inc. will post 3.37 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Zacks Research lowered Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Merit Medical Systems in a research note on Monday. Robert W. Baird set a $103.00 price target on shares of Merit Medical Systems in a report on Friday, October 31st. Needham & Company LLC reiterated a “buy” rating and issued a $108.00 price objective on shares of Merit Medical Systems in a research note on Friday, October 31st. Finally, Canaccord Genuity Group lowered their target price on shares of Merit Medical Systems from $104.00 to $93.00 and set a “buy” rating on the stock in a research report on Friday, November 14th. Eight research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $104.50.

Institutional Investors Weigh In On Merit Medical Systems

A number of large investors have recently added to or reduced their stakes in MMSI. Amundi raised its holdings in shares of Merit Medical Systems by 2.2% in the 1st quarter. Amundi now owns 132,780 shares of the medical instruments supplier’s stock worth $13,804,000 after purchasing an additional 2,847 shares during the period. Wellington Management Group LLP grew its stake in Merit Medical Systems by 15.3% during the first quarter. Wellington Management Group LLP now owns 260,084 shares of the medical instruments supplier’s stock worth $27,493,000 after buying an additional 34,448 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in shares of Merit Medical Systems by 119.8% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 367 shares of the medical instruments supplier’s stock worth $39,000 after acquiring an additional 200 shares in the last quarter. Fred Alger Management LLC increased its position in shares of Merit Medical Systems by 22.9% in the first quarter. Fred Alger Management LLC now owns 154,707 shares of the medical instruments supplier’s stock worth $16,354,000 after acquiring an additional 28,793 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Merit Medical Systems by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,967 shares of the medical instruments supplier’s stock valued at $3,908,000 after acquiring an additional 1,436 shares during the period. 99.66% of the stock is owned by institutional investors and hedge funds.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.